FDA loosens rules on compounded IV nutrition for preemies after two suppliers close
Federal agency temporarily relaxes compounding restrictions to address a potential shortage of specialized intravenous nutrition for premature and critically ill newborns.
The Food and Drug Administration is temporarily loosening rules around compounded nutrition products for premature and critically ill newborns after two facilities that supply the specialized IV formula announced they are permanently shutting down.